• No se han encontrado resultados

hearts? Am . J. Physiol. (1995); 268: H426-H431

100. Ytrehus K, Liu Y and Downey J M. Preconditioning protects ischemic rabbit heart by

protein kinase C activation. Am . J. Physiol. (1994); 266: H1145-H1152

101. Liu Y, Cohen M and Downey J. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the antiinfarct effect of ischemic preconditioning in rabbit hearts.

Cardiovasc. D rugs Ther. (1994); 8: 881-882

102. Przyklenk K, Sussman M, Simkhovich BZ and Kloner RA. Does ischemic preconditioning

trigger translocation of protein kinase C in canine model? C irculation (1995); 92:

1546-1557

103. Vahlhaus C, Schulz R, Post H, Onallah R and Heusch G. N o prevention of ischemic

preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ. R es.

(1996); 79: 407-414

104. Steinberg S F, Goldberg M and Rybin V O. Protein kinase C isoform diversity in the heart. /. M ol. Cell. Cardiol. (1995); 27: 141-153

105. Nishizuka Y. Studies and perspectives of protein kinase C. Science (1986); 233: 305-312

106. Liu Y, Ytrehus K and Downey J M. Evidence that translocation of protein kinase C is a key

event during ischemic preconditioning of rabbit myocardium. /. Mol. Cell. Cardiol. (1994);

26: 661-668

107. Ping P, Zhang J, Qiu Y, Tang X-L, Manchikalapudi S, Gao X and Bolli R. Ischemic

preconditioning induces selective translocation of protein kinase C isoforms e and T| in th e

heart of conscious rabbits without subcellular redistribution of total protein kinase C

References

108. Gray M O, Karliner J S and Mochly-Rosen D. A selective e-protein kinase C antagonist

inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. C h e m .

(1997); 272: 30945-30951

109. Zhao J, Renner O, Wightman L, Sugden P H, Stewart L, Miller A D, Latchman D S and

Marber M S. The expression of constitutively active isotypes of protein kinase C to

investigate preconditioning. /. B iol Chem. (1998); 273: 23072-23079

110. Yang X-M, Sato H, Downey J M and Cohen M V. Protection of ischemic preconditioning is

dependent upon a critical timing sequence of protein kinase C activation. /. M ol. C e ll.

C ardiol (1997); 29: 991-999

111. Baines C P, Wang L, Cohen M V and Downey J M. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. /. M o l C e ll C ardiol (1998); 30: 383-39

112. Maulik N , Yoshida T, Engelman R M and Das D K. Tyrosine kinase regulation of HSP 27

and HSP 70 gene expression in ischemically preconditioned hearts. /. M ol. Cell. C a r d io l.

(1997); 29: A171

113. Baines C P, Cohen M V and Downey J M. Protein tyrosine kinase inhibitor, genistein,

blocks preconditioning in isolated rabbit hearts. Circulation (1996); 28: 1-661

114. Kitakaze M, N od e K, Funaya H, Mizukami Y-I and Yoshida K-I. Tyrosine kinase is not involved in the infarct size limiting effect of ischemic preconditioning in the canine

heart. C irculation (1997); 96: 1-574

115. Maulik N, Yoshida T, Zu Y-L and Das D K. Ischemic preconditioning triggers a tyrosine kinase-dependent signal transduction process involving p ^ MAP kinases and MAPKAP

kinase 2. /. M ol. C e ll C ardiol (1997); 29: A171

116. Bogoyevitch M A, Gillespie-Brown J, Ketterman A J, Fuller S J, Ben-Levy R, Ashworth A, Marshall C J and Sugden P H. Stimulation of the stress-activated m itogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases

and c-Jim N-terminal kinases are activated by ischemia/ reperfusion. Circ. Res. (1996); 79:

162-173

117. Raingeaud J, Gupta S, Rogers J S, Dickens M, Han J, Ulevich R J and Davis R J. Pro-inflammatory cytokines and environmental stress cause p38 m itogen-activated

protein kinase activation by dual phosphorylation on tyrosine and threonine. /. B io l.

118. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T and Nebreda A R. A novel kinase cascade triggered by stress and heat shock that stim ulates

MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell (1994);

78: 1027-1037

119. Guyton K Z , Liu Y, Gorospe M, Xu Q and Holbrook N J. Activation of m itogen-activated

protein kinase by H2O2. Role in cell survival following oxidant injury. /. Biol. C h e m .

(1996); 271: 4138-4142

120. Weinbrenner C, Liu G-S, Cohen M V and Downey J M. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in

the rabbit. J. M ol. Cell. Cardiol. (1997); 29: 2383-2391

121. Kim S O, Salh B, Pelech S L, Wong G and Katz S. Activation of MAPKAP kinase-2 by

adenosine in rat heart. /. N IH Res. (1997); 9: 54

122. Gross G J and Auchampach J A. Blockade of ATP-sensitive potassium channels prevents

myocardial preconditioning in dogs. Circ. Res. (1992); 70: 223-233

123. Cleveland J C, Meldrum D R, Cain B S, Banerjee A and Harken A H. Oral sulphonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium.

Two paradoxes revisited. Circulation (1997); 96: 29-32

124. Rohmann S, Weygandt H, Schelling P, Soei K, Verdouw P D and Lues I. Involvement of

ATP-sensitive potassium charmels in preconditioning protection. Basic Res. C a r d io l.

(1994); 89: 563-576

125. Armstrong S C, Liu G S, Downey J M and Ganote C E. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and p inacid il. /. M ol. Cell. Cardiol. (1995); 27: 1765-1774

126. Schultz J E J, Qian Y Z , Gross G J and Kukreja R C. The ischem ia-selective Ky^^p channel

antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. /. M ol. Cell. Cardiol. (1997); 29: 1055-1060

127. Hearse D J. Activation of ATP-sensitive potassium channels: A novel pharm acological

approach to myocardial protection. In: Yellon D M and Gross G J, eds. M y o c a r d ia l

protection and the channel. (1995) Kluwer Academic Publishers, Boston, USA, pp 51-98

128. Ford W R, Lopaschuk G D, Schulz R and Clanachan A S. Ky^-pp-chaimel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to

References

129. Cleveland J C, Meldrum J D R, Rowland R T, Banerjee A and Harken A H. Adenosine

preconditioning of human myocardium is dependent upon the ATP-sensitive channel.

/. M o l C ell C ardiol (1997); 29: 175-182

130. Kouchi I, Murakami T, Nawada R, Akao M and Sasayama S. K^-jp channels are commcn

mediators of ischemic and calcium preconditioning in rabbits. A m . J. P h y s io l (1998); 274:

H1106-H1112

131. Schultz J, Hsu A K, Nagase H and Gross G J. TAN-67, a 8j-opioid receptor agonist, reduces

infarct size via activation of G^/q proteins and K^yp channels. A m . }. P h ysio l (1998); 274:

H909-H914

132. Hide E J, Ney P, Piper J, Thiemermann C and Vane J R. Reduction by prostaglandin Ej or prostaglandin Eg of myocardial infarct size in the rabbit by activation of ATP-sensitive

potassium channels. Br. J. Pharmacol (1995); 116: 2435-2440

133. Turrens J F, Thornton J, Barnard M L, Snyder S, Liu G and Downey J M. Protection from reperfusion injury by preconditioning hearts does not involve increased antioxidant

defenses. Am . J. Physiol. (1992); 262: H585-H589

134. Hoshida S, Kuzuya T, Fuji H, Yamashita N, Oe H, Hori M, Suzuki K, Taniguchi N and Tada M. Sublethal ischemia alters myocardial antioxidant activity in canine heart.

A m . J. P h ysio l (1993); 264: H33-H39

135. Das D K, Engelman R M and Kimura Y. Molecular adaptation of cellular defences

following preconditioning of the heart by repeated ischaemia. C ardiovasc. Res. (1993);

27: 578-584

136. Murry C E, Richard V J, Reimer K A and Jennings R B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic

episode. Circ. Res. (1990); 6 6: 913-931

137. Kida M, Fujiwara H, Ishida M, Kawai C, Ghura M, Miura I and Yabuuchi Y. Ischemic

preconditioning preserves creatine phosphate and intracellular pH. C irculation (1991);

84: 2495-2503

138. Yabe K, Nasa Y, Sato M, lijima R and Takeo S. Preconditioning preserves m itochondrial function and glycolytic flux during an early period of reperfusion in perfused rat hearts.

139. Kobara M, Tatsumi T, Matoba S, Yamahara Y, Nakagawa C, Ohta B, Matsumoto T, Inoue D, Asayama J and Nakagawa M. Effect of ischemic preconditioning on m itochondrial

oxidative phosphorylation and high energy phosphates in rat hearts. /. M ol. C e ll.

Cardiol. (1996); 28: 417-428

140. Ganote C and Armstrong S. Ischaemia and the myocyte cytoskeleton: review and

speculation. Cardiovasc. Res. (1993); 27: 1387-1403

141. Baxter G F, Marber M S, Patel V C and Yellon D M. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischaemic preconditioning.

C irculation (1994); 90: 2993-3000

142. Baxter G F and Yellon D M. Time course of delayed myocardial protection after transient

adenosine A^-receptor activation in the rabbit. }. C ardiovasc. Pharm acol. (1997); 29:

631-638

143. Dana A , Baxter G F, Walker J M and Yellon D M. Prolonging the delayed phase of

myocardial protection: repetitive adenosine A^ receptor activation maintains rabbit

myocardium in a preconditioned state. J. A m . Coll. Cardiol. (1998); 31: 1142-1149

144. Sun J-X, Tang X-L, Park S-W, Qiu Y, Turrens J F and Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against m yocardial

stunning in conscious pigs. J. Clin. Invest. (1996); 97: 562-576

145. Bolli R, Bhatti Z A, Tang X-L, Qiu Y, Zhang Q, Guo Y and Jadoon A K. Evidence that la te preconditioning against myocardial stunning in consduos rabbits is triggered by th e

generation of nitric oxide. Circ. Res. (1997); 81: 42-52

146. Baxter G F, Goma F M and Yellon D M. Involvement of protein kinase C in the d ela y ed

cytoprotection following sublethal ischaemia in rabbit myocardium. Br. }. P h a r m a c o l.

(1995); 115: 222-224

147. Baxter G F, Mocanu M M and Yellon D M. Attenuation of myocardial ischaemic injury 24 h

after diacylglycerol treatment in vivo. J. M ol. Cell. Cardiol. (1997); 29: 1967-1975

148. Dana A, Yamashita N , Baxter G F and Yellon D M. Involvement of protein kinases and

manganese-superoxide dismutase in adenosine induced delayed preconditioning.